These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Effect of ornid on the regulation of cerebrovascular circulation]. Mirzoian RS Biull Eksp Biol Med; 1979 May; 87(5):427-9. PubMed ID: 454820 [TBL] [Abstract][Full Text] [Related]
25. Bretylium tosylate and ventricular fibrillation in hypothermia. Kochar G; Kahn SE; Kotler MN Ann Intern Med; 1986 Oct; 105(4):624. PubMed ID: 3752772 [No Abstract] [Full Text] [Related]
26. [Homeostatic indices in peritonitis following specific correction of microcirculatory disorders]. Shal'kov IuL; Lazarev AV Anesteziol Reanimatol; 1981; (2):53-5. PubMed ID: 7270978 [No Abstract] [Full Text] [Related]
27. Questions arise over bretylium study. Ann Emerg Med; 1982 Jan; 11(1):54-6. PubMed ID: 7055354 [No Abstract] [Full Text] [Related]
28. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction. Dhurandhar RW; Pickron J; Goldman AM Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604 [TBL] [Abstract][Full Text] [Related]
29. Bretylium tosylate therapy for ventricular fibrillation after cardiopulmonary bypass. Santora AH; Finucane BT South Med J; 1983 Sep; 76(9):1197-8. PubMed ID: 6612407 [TBL] [Abstract][Full Text] [Related]
30. The use of bretylium in prehospital ventricular fibrillation. Harrison EE; Amey BD Am J Emerg Med; 1983 Jul; 1(1):1-6. PubMed ID: 6680596 [TBL] [Abstract][Full Text] [Related]
31. Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted. Bacaner M Int J Cardiol; 1983 Sep; 4(2):133-52. PubMed ID: 6354941 [No Abstract] [Full Text] [Related]
32. Chemical ventricular defibrillation in severe accidental hypothermia. Danzl DF; Sowers MB; Vicario SJ; Thomas DM; Miller JW Ann Emerg Med; 1982 Dec; 11(12):698-9. PubMed ID: 7149370 [No Abstract] [Full Text] [Related]
33. Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate. Goldberger AL; Pavelec RS Int J Cardiol; 1986 Oct; 13(1):47-55. PubMed ID: 3771001 [TBL] [Abstract][Full Text] [Related]
34. Bretylium: a prototype for future development of antidysrhythmic agents. Patterson E; Lucchesi BR Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235 [No Abstract] [Full Text] [Related]
35. Oral bretylium tosylate use during pregnancy and subsequent breastfeeding: a case report. Gutgesell M; Overholt E; Boyle R Am J Perinatol; 1990 Apr; 7(2):144-5. PubMed ID: 2331276 [TBL] [Abstract][Full Text] [Related]
37. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias. Kron IL; Nolan SP Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915 [TBL] [Abstract][Full Text] [Related]
38. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Anderson JL Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143 [TBL] [Abstract][Full Text] [Related]
40. [Ornid but not atropine abolishes the insulin receptor reaction of fat and liver plasma membranes to fasting and hyperinsulinemia]. Bezdrobnyĭ IuV; Evdokimova NIu Fiziol Zh SSSR Im I M Sechenova; 1984 Feb; 70(2):200-5. PubMed ID: 6370738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]